ReN-1869 hydrochloride is a selective histamine H1 receptor antagonist with potential anti-inflammatory and antihistaminic applications; it significantly inhibits histamine-evoked paw edema in vivo (ED50 ≈ 300 μg/kg) and demonstrates functional H1 receptor antagonism without affecting carrageenan-induced paw edema, suggesting its utility in conditions involving histamine-mediated inflammation.